Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Ionis Pharmaceuticals Inc. (IONS) (IONS)

53   0.5 (0.95%) 04-09 16:00
Open: 52.06 Pre. Close: 52.5
High: 53.39 Low: 52.06
Volume: 547,574 Market Cap: 7379M
Ionis Pharmaceuticals Inc is the RNA-targeted drug discovery and development company. Its broad pipeline consists of close to 32 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe, and rare diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 52.999 - 53.256 53.256 - 53.478
Low: 49.189 - 49.474 49.474 - 49.72
Close: 52.055 - 52.516 52.516 - 52.913

Technical analysis

as of: 2020-04-09 3:59:08 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 63.12     One year: 73.72
Support: Support1: 44.94    Support2: 39.32
Resistance: Resistance1: 54.04    Resistance2: 63.12
Pivot: 48.18
Moving Average: MA(5): 51.07     MA(20): 47.42
MA(100): 57.34     MA(250): 61.62
MACD: MACD(12,26): -0.13     Signal(9): -1.23
Stochastic oscillator: %K(14,3): 90.29     %D(3): 89.00
RSI: RSI(14): 56.30
52-week: High: 85.88  Low: 39.32  Change(%): -37.6
Average Vol(K): 3-Month: 103710  10-Days: 83366

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
IONS has closed below upper band by 11.9%. Bollinger Bands are 51.2% wider than normal. The large width of the bands suggest high volatility as compared to IONS's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Why Ionis Pharmaceuticals (IONS) Stock Might be a Great Pick
Ionis Pharmaceuticals (IONS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well

The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Biochem, Inc. (NYSE: ENZ ) Centogene NV (NASDAQ: CNTG ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Spherix Inc (NASDAQ: SPEX ) ( added to Friday's advance on clinching an option agreement for coronavirus treatment) Down In The Dumps (Biotech stocks that hit 52-week lows March 9.) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alexion Pharmaceuticals, Inc.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 140.66
Shares Float (M) 132.19
% Held by Insiders 5.03
% Held by Institutions 88.15
Shares Short (K) 8800
Shares Short P. Month (K) 9700

Stock Financials

EPS 2.080
Book Value (p.s.) 10.480
PEG Ratio
Profit Margin 26.20
Operating Margin 32.79
Return on Assets (ttm) 7.8
Return on Equity (ttm) 21.1
Qtrly Rev. Growth 157.0
Gross Profit (p.s.) 4.655
Sales Per Share 7.962
EBITDA (p.s.) 2.720
Qtrly Earnings Growth -42.40
Operating Cash Flow (M) 345.72
Levered Free Cash Flow (M) 278.99

Stock Valuations

P/E 25.39
P/E Growth Ratio 0.01
P/BV 5.04
P/CF 21.49

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.